Share on LinkedInShare on LinkedIn

ARTICLE · 13 AUGUST 2020

Prosecution History Estoppel And Claim Vitiation Not Enough To Avoid Willful Infringement

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

In Bio-Rad Labs., Inc. v. 10X Genomics Inc., No. 2019-2255 (Fed. Cir. Aug. 3, 2020), the Federal Circuit rejected 10X's prosecution history

United StatesIntellectual Property

In Bio-Rad Labs., Inc. v. 10X Genomics Inc., No. 2019-2255 (Fed. Cir. Aug. 3, 2020), the Federal Circuit rejected 10X's prosecution history estoppel and claim vitiation defenses and upheld the jury's finding of willful infringement under the doctrine of equivalents.

Bio-Rad sued 10X for infringement of three patents covering microscopic droplets of fluids for biochemical reactions, often called "labs-on-a-chip." Bio-Rad amended the patents' claim language during prosecution to claim "a non-fluorinated microchannel," and further argued that, unlike the prior art, the claims require the microchannel be "chemically similar to the carrier fluid and chemically different from the channel walls." 10X argued that its product, which includes 0.02% of a fluorine-containing resin in its microchannels, did not infringe.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from